CN112044289B - 一种高效能血液透析仪器用透析膜及制备方法 - Google Patents
一种高效能血液透析仪器用透析膜及制备方法 Download PDFInfo
- Publication number
- CN112044289B CN112044289B CN202010978940.3A CN202010978940A CN112044289B CN 112044289 B CN112044289 B CN 112044289B CN 202010978940 A CN202010978940 A CN 202010978940A CN 112044289 B CN112044289 B CN 112044289B
- Authority
- CN
- China
- Prior art keywords
- membrane
- hollow fiber
- parts
- weight
- spinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 155
- 238000000502 dialysis Methods 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 19
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 19
- 239000012510 hollow fiber Substances 0.000 claims abstract description 79
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 45
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 44
- 239000002904 solvent Substances 0.000 claims abstract description 33
- 239000001913 cellulose Substances 0.000 claims abstract description 31
- 229920002678 cellulose Polymers 0.000 claims abstract description 31
- 229920002492 poly(sulfone) Polymers 0.000 claims abstract description 31
- 239000011347 resin Substances 0.000 claims abstract description 31
- 229920005989 resin Polymers 0.000 claims abstract description 31
- 239000002270 dispersing agent Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000000853 adhesive Substances 0.000 claims abstract description 18
- 230000001070 adhesive effect Effects 0.000 claims abstract description 18
- 238000000578 dry spinning Methods 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 17
- 239000000499 gel Substances 0.000 claims description 47
- 238000009987 spinning Methods 0.000 claims description 45
- 239000002994 raw material Substances 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 30
- 238000005266 casting Methods 0.000 claims description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 15
- 230000001681 protective effect Effects 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 11
- 239000007789 gas Substances 0.000 claims description 10
- 239000000017 hydrogel Substances 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 6
- 238000001891 gel spinning Methods 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 208000037516 chromosome inversion disease Diseases 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000009826 distribution Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000000614 phase inversion technique Methods 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims 1
- 230000010100 anticoagulation Effects 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical group CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 10
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 9
- 229960002897 heparin Drugs 0.000 description 9
- 229920000669 heparin Polymers 0.000 description 9
- 229920001661 Chitosan Polymers 0.000 description 8
- 108010039918 Polylysine Proteins 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 229920000656 polylysine Polymers 0.000 description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 6
- 239000002105 nanoparticle Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 238000009941 weaving Methods 0.000 description 3
- 238000005452 bending Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- FYIBGDKNYYMMAG-UHFFFAOYSA-N ethane-1,2-diol;terephthalic acid Chemical compound OCCO.OC(=O)C1=CC=C(C(O)=O)C=C1 FYIBGDKNYYMMAG-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
- B01D71/68—Polysulfones; Polyethersulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0013—Casting processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0016—Coagulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/087—Details relating to the spinning process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/24—Mechanical properties, e.g. strength
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Water Supply & Treatment (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010978940.3A CN112044289B (zh) | 2020-09-17 | 2020-09-17 | 一种高效能血液透析仪器用透析膜及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010978940.3A CN112044289B (zh) | 2020-09-17 | 2020-09-17 | 一种高效能血液透析仪器用透析膜及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112044289A CN112044289A (zh) | 2020-12-08 |
CN112044289B true CN112044289B (zh) | 2022-04-19 |
Family
ID=73603326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010978940.3A Active CN112044289B (zh) | 2020-09-17 | 2020-09-17 | 一种高效能血液透析仪器用透析膜及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112044289B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285399C (zh) * | 2003-08-13 | 2006-11-22 | 天津膜天膜工程技术有限公司 | 用于血液透析的聚偏氟乙烯中空纤维膜 |
DE112016001400T5 (de) * | 2015-04-23 | 2017-12-21 | Aethlon Medical, Inc. | Verfahren zur Verabreichung regionaler Citratantikoagulation (RCA) während extrakorporaler Blutbehandlungen |
CN104984670A (zh) * | 2015-06-24 | 2015-10-21 | 苏州乔纳森新材料科技有限公司 | 一种血液净化膜及其制备方法 |
CN108816054B (zh) * | 2018-06-18 | 2021-06-18 | 杜艺 | 一种血液透析仪器用的透析膜的制备方法 |
CN109603591A (zh) * | 2019-01-18 | 2019-04-12 | 苏州君康医疗科技有限公司 | 抗凝血复合中空纤维膜及制备方法 |
-
2020
- 2020-09-17 CN CN202010978940.3A patent/CN112044289B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112044289A (zh) | 2020-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2916446B2 (ja) | 非対称微孔性中空繊維の製造方法 | |
CN101703893B (zh) | 空心纤维超滤复合膜及其制备方法和应用 | |
CN102961977B (zh) | 一种聚乳酸中空纤维透析膜的制备方法 | |
US8435751B2 (en) | Membrane for cell expansion | |
EP2329010B1 (en) | Device for renal cell expansion | |
US20150060372A1 (en) | Low cut-off ultrafiltration membranes | |
US4749619A (en) | Hollow fibre useful in blood treating processes | |
CN110079887A (zh) | 用于纤维形成的性能增强用添加剂和聚砜纤维 | |
CN105363358B (zh) | 聚醚砜/聚碳酸丁二醇酯中空纤维共混膜及制备方法 | |
CN105521715B (zh) | 一种共混聚偏氟乙烯中空纤维膜及其制备方法 | |
JPH10108907A (ja) | 血液浄化膜、その製造方法及び血液浄化用モジュール | |
CN105013355B (zh) | 类肝素化聚醚砜中空纤维膜及其制备方法与用途 | |
CN110756066B (zh) | 一种磺化柠檬酸壳聚糖改性聚砜血液透析膜及其制备方法 | |
CN112044289B (zh) | 一种高效能血液透析仪器用透析膜及制备方法 | |
IE55578B1 (en) | Hollow fibre useful in blood treating processes | |
CN114504953B (zh) | 一种中空纤维血液透析膜的制备方法 | |
CN104437133A (zh) | 一种海藻纤维血液透析膜及其制备方法 | |
CN109316985B (zh) | 一种磺化二羟丙基壳聚糖改性聚氨酯血液透析膜及其制备方法 | |
CN114749032B (zh) | 一种pmp中空纤维膜及其制备方法和应用 | |
Paul | Polymer hollow fiber membranes for removal of toxic substances from blood | |
CN114232129B (zh) | 聚醚砜纤维及其制备方法和用途 | |
CN113262341B (zh) | 体外膜肺氧合器用中空纤维膜及其制备方法 | |
KR102593611B1 (ko) | 셀룰로오스계 고분자 정밀여과 분리막의 제조방법 | |
CN117414709A (zh) | 聚醚砜双o-乙酰化甲壳素共混中空纤维膜及其制备方法 | |
CN114749036A (zh) | 一种中空纤维异质膜及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240301 Address after: Building 18, No. 333, Guanpu Road, Guoxiang Street, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province 215100 Patentee after: JIANGSU GUANHUAI MEDICAL TECHNOLOGY Co.,Ltd. Country or region after: China Address before: 215000 1f, building 2, 111 Wusongjiang Avenue, Guoxiang street, Wuzhong District, Suzhou City, Jiangsu Province Patentee before: Suzhou care new material technology research Co.,Ltd. Country or region before: China |